We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effect of Healing on Rheumatoid Arthritis (RAhealing)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00967395
Recruitment Status : Completed
First Posted : August 27, 2009
Last Update Posted : January 6, 2012
The IMK Foundation
The Danish Rheumatism Association
Oak Foundation
Information provided by (Responsible Party):
Henning Bliddal, Frederiksberg University Hospital

Brief Summary:
The hypothesis is that healing may influence the patient's general status by altering psychological as well as other body functions of importance for the rheumatoid arthritis. This is tested in a three group design with a control group and two groups receiving healing with or without a healer present. The study is randomized and double blind.

Condition or disease Intervention/treatment
Rheumatoid Arthritis Other: Healing Other: Sham healing

Detailed Description:
The central claim of healers is that this process facilitates self-healing in the patient. Spiritual healing includes several categories, including 'therapeutic touch' and 'intercessory prayer', and the healing may be attributed to God, spirits, universal forces or energies, biological healing energies residing in the healer, or self-healing powers or energies thought to reside latent in the healed organism. The highly controversial hypothesized effects of distant or spiritual healing contradict our traditional sense of reality and are in conflict with what is generally viewed as being in correspondence with modern science.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: Effect of Healing on Rheumatoid Arthritis: a Three-arm Double-blind, Randomized, Controlled Trial
Study Start Date : January 2008
Primary Completion Date : January 2009
Study Completion Date : September 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Healing
patients receive healing while blindfolded and with hearing protector. The healer is behind a screen and not allowed to speak with the subject.
Other: Healing
Healing in our study is given be a healer "no-touch", who just has to be present in the room.
Other Name: "active healing"
Sham Comparator: Sham healing
Same design of room as with the healing, while in this case a student is behind the screen
Other: Sham healing
Sham Healing in our study is given be a student "no-touch", who just has to be present in the room.
Other Name: "placebo healing"
No Intervention: Control
Business as usual in the third arm

Primary Outcome Measures :
  1. DAS28 [ Time Frame: 8 weeks follow-up ]

Secondary Outcome Measures :
  1. Colour Doppler fraction [ Time Frame: 8 weeks follow-up ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with rheumatoid arthritis in a stable medication the past 3 months written informed consent

Exclusion Criteria:

  • Not able to arrange own transport, language problems

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00967395

Sponsors and Collaborators
Henning Bliddal
The IMK Foundation
The Danish Rheumatism Association
Oak Foundation
Study Director: Bente Danneskiold-Samsøe, Professor Frederiksberg University Hospital

Responsible Party: Henning Bliddal, Professor, Frederiksberg University Hospital
ClinicalTrials.gov Identifier: NCT00967395     History of Changes
Other Study ID Numbers: (KF) 01-123/04
First Posted: August 27, 2009    Key Record Dates
Last Update Posted: January 6, 2012
Last Verified: January 2012

Additional relevant MeSH terms:
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases